NovoThirteen

recombinant factor XIII (rFXIII) · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NovoThirteen, covering 2022-03-21 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan

See pricing